ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001285648

Cauwenbergh Geert

CIK 0001285648 Name as filed on the most recent filing

Filed as Cauwenbergh Geert (59)

117 transaction lines · from 59 filings · filed 2004-05-06 to 2017-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

117 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2017-10-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 7,100 acquired 0.45 3,195.00 Form 4, filing 0001209191-17-054555
2017-10-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 2,700 acquired 0.44 1,188.00 Form 4, filing 0001209191-17-054555
2017-10-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 200 acquired 0.46 92.00 Form 4, filing 0001209191-17-054555
2017-08-24 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 4,900 acquired 0.54 2,670.50 Form 4, filing 0001209191-17-050044
2017-08-24 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 4,361 acquired 0.55 2,398.55 Form 4, filing 0001209191-17-050044
2017-08-24 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 739 acquired 0.56 413.84 Form 4, filing 0001209191-17-050044
2017-06-22 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 5,000 acquired 0.63 3,150.00 Form 4, filing 0001209191-17-041289
2017-06-22 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 5,000 acquired 0.62 3,100.00 Form 4, filing 0001209191-17-041289
2017-04-26 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 10,000 acquired 0.65 6,480.00 Form 4, filing 0001209191-17-028187
2017-03-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 9,320 acquired 0.77 7,171.74 Form 4, filing 0001209191-17-021599
2017-03-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 665 acquired 0.77 508.79 Form 4, filing 0001209191-17-021599
2017-03-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 15 acquired 0.77 11.48 Form 4, filing 0001209191-17-021599
2017-02-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 6,883 acquired 0.69 4,765.79 Form 4, filing 0001209191-17-012427
2017-02-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 2,917 acquired 0.70 2,027.32 Form 4, filing 0001209191-17-012427
2017-02-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 200 acquired 0.69 138.30 Form 4, filing 0001209191-17-012427
2017-02-08 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 10,000 acquired 0.68 6,850.00 Form 4, filing 0001209191-17-008542
2017-01-25 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 9,700 acquired 0.70 6,758.96 Form 4, filing 0001209191-17-005642
2017-01-25 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 300 acquired 0.69 207.00 Form 4, filing 0001209191-17-005642
2017-01-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 6,400 acquired 0.70 4,448.00 Form 4, filing 0001209191-17-004383
2017-01-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 3,000 acquired 0.69 2,083.80 Form 4, filing 0001209191-17-004383
2017-01-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 600 acquired 0.69 416.94 Form 4, filing 0001209191-17-004383
2015-04-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 5,000 acquired 0.72 3,596.00 Form 4, filing 0001209191-15-031113
2015-02-17 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 4,000 acquired 1.17 4,680.00 Form 4, filing 0001209191-15-015052
2015-02-10 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,156 acquired 1.25 1,444.88 Form 4, filing 0001209191-15-011758
2015-02-10 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 644 acquired 1.24 798.56 Form 4, filing 0001209191-15-011758
2015-02-10 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 200 acquired 1.22 244.00 Form 4, filing 0001209191-15-011758
2015-01-20 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 10,000 acquired 1.03 10,300.00 Form 4, filing 0001209191-15-004882
2014-12-30 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 2,000 acquired 1.59 3,173.40 Form 4, filing 0001209191-14-078466
2014-12-30 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 500 acquired 1.59 794.65 Form 4, filing 0001209191-14-078466
2014-10-13 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 3,000 acquired 1.68 5,039.70 Form 4, filing 0001181431-14-034213
2014-09-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 4,500 acquired 2.20 9,900.00 Form 4, filing 0001181431-14-032520
2014-09-16 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 5,000 acquired 2.08 10,390.00 Form 4, filing 0001181431-14-032060
2014-09-15 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 5,000 acquired 2.18 10,899.50 Form 4, filing 0001181431-14-031916
2014-09-15 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 3,000 acquired 2.19 6,569.70 Form 4, filing 0001181431-14-031916
2014-09-15 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 2,000 acquired 2.19 4,380.00 Form 4, filing 0001181431-14-031916
2014-07-15 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,000 acquired 2.50 2,500.00 Form 4, filing 0001181431-14-026895
2014-07-09 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,400 acquired 2.57 3,597.86 Form 4, filing 0001181431-14-026445
2014-07-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,000 acquired 2.86 2,859.90 Form 4, filing 0001181431-14-025698
2014-07-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 700 acquired 2.85 1,995.00 Form 4, filing 0001181431-14-025698
2014-07-02 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 300 acquired 2.86 858.00 Form 4, filing 0001181431-14-025698
2014-06-25 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 500 acquired 3.01 1,505.00 Form 4, filing 0001181431-14-025043
2014-06-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,000 acquired 2.99 2,992.10 Form 4, filing 0001181431-14-024489
2014-06-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 800 acquired 2.96 2,368.00 Form 4, filing 0001181431-14-024489
2014-06-19 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 200 acquired 3.00 600.00 Form 4, filing 0001181431-14-024489
2014-06-09 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 800 acquired 3.05 2,439.92 Form 4, filing 0001181431-14-023239
2014-06-09 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 200 acquired 3.05 610.00 Form 4, filing 0001181431-14-023239
2014-06-04 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,000 acquired 2.97 2,971.50 Form 4, filing 0001181431-14-022758
2014-06-04 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 1,000 acquired 2.91 2,914.00 Form 4, filing 0001181431-14-022758
2013-10-31 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 800 acquired 3.19 2,552.00 Form 4, filing 0001181431-13-056063
2013-10-30 RXi Pharmaceuticals Corp
RXII 		P, Open-market purchase 200 acquired 3.09 618.00 Form 4, filing 0001181431-13-056063

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 117
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. CAUWENBERGH GEERT, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001285648

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.